These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38362536)

  • 1. Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literature.
    Khorasanchi A; Korman AM; Manne A; Meara A
    Front Med (Lausanne); 2024; 11():1334718. PubMed ID: 38362536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.
    Marano AL; Clarke JM; Morse MA; Shah A; Barrow W; Selim MA; Hall RP; Cardones AR
    Br J Dermatol; 2019 Sep; 181(3):580-583. PubMed ID: 30244487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute cutaneous lupus erythematosus induced by nivolumab: two case reports and a literature review.
    Zitouni NB; Arnault JP; Dadban A; Attencourt C; Lok CC; Chaby G
    Melanoma Res; 2019 Apr; 29(2):212-215. PubMed ID: 30489484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.
    Figueredo Zamora E; Callen JP; Schadt CR
    Lupus; 2021 Apr; 30(4):661-663. PubMed ID: 33349110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subacute cutaneous lupus erythematosus with a possible paraneoplastic association with melanoma.
    Hirner J
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31780613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoint Inhibitors and Lupus Erythematosus.
    Vitzthum von Eckstaedt H; Singh A; Reid P; Trotter K
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review.
    Pratumchart N; Chanprapaph K; Topibulpong N; Tankunakorn J
    Clin Cosmet Investig Dermatol; 2022; 15():51-62. PubMed ID: 35046689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation.
    Bui AN; Hirner J; Singer SB; Eberly-Puleo A; Larocca C; Lian CG; LeBoeuf NR
    Clin Exp Dermatol; 2021 Mar; 46(2):328-337. PubMed ID: 32939795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread subacute cutaneous lupus erythematosus in a patient receiving checkpoint inhibitor immunotherapy with ipilimumab and nivolumab.
    Kosche C; Owen JL; Choi JN
    Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.
    Deng Z; Guo A; Wu C; Wang C
    J Cosmet Dermatol; 2022 Dec; 21(12):7202-7208. PubMed ID: 36214602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute cutaneous lupus erythematosus with a psoriasiform presentation: A diagnostic clinical conundrum.
    Razi S; Truong TM; Sekhon P; Ouellette S; Rao BK
    Clin Case Rep; 2023 Sep; 11(9):e7893. PubMed ID: 37736481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report.
    Xu K; Zhang M; Yang S; Yu G; Zheng P; Qin X; Feng J
    BMC Neurol; 2023 Apr; 23(1):168. PubMed ID: 37101279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rowell's Syndrome Triggered by Omeprazole.
    Pozharashka J; Dourmishev L; Balabanova M; Vassileva S; Miteva L
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):124-126. PubMed ID: 31351509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in
    Ferro A; Filoni A; Pavan A; Pasello G; Guarneri V; Conte P; Alaibac M; Bonanno L
    Front Med (Lausanne); 2021; 8():570921. PubMed ID: 34179028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature.
    Kaur S; Singla P; Kaur S; Kansal A; Bansal A; Singh A
    Indian Dermatol Online J; 2022; 13(1):64-72. PubMed ID: 35198470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic subacute cutaneous lupus erythematosus: an underrecognized entity.
    Evans KG; Heymann WR
    Cutis; 2013 Jan; 91(1):25-9. PubMed ID: 23461055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitor-induced diabetes mellitus with nivolumab.
    Zand Irani A; Gibbons H; Teh WX
    BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37011994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands.
    Ramachandran SM; Leventhal JS; Franco LG; Mir A; Walters RF; Franks AG
    Lupus Sci Med; 2017; 4(1):e000207. PubMed ID: 28331627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.